TWC
RVMD icon

TD Waterhouse Canada’s Revolution Medicines RVMD Stock Holding History

TD Waterhouse Canada’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6K Hold
270
– – ﹤0.01% 1413
2026
Q1 		$26.6K Buy
270
+70
+35% +$7.07K ﹤0.01% 1526
2025
Q4 		$15.9K Buy
+200
New +$13.1K ﹤0.01% 1444
2024
Q4 		– Sell
-249
Closed -$11.2K – 2041
2024
Q3 		$11.2K Hold
249
– – ﹤0.01% 1341
2024
Q2 		$9.71K Hold
249
– – ﹤0.01% 1372
2024
Q1 		$10.4K Hold
249
– – ﹤0.01% 1363
2023
Q4 		$9.32K Buy
+249
New +$5.98K ﹤0.01% 1270

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

TD Waterhouse Canada's RVMD Position: Q2 2026 in Review

TD Waterhouse Canada held its Revolution Medicines (RVMD) position steady in Q2 2026 at 270 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

TD Waterhouse Canada first reported a position in RVMD in Q4 2023 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • TD Waterhouse Canada held 270 shares of Revolution Medicines worth $50.6K as of Q2 2026.
  • TD Waterhouse Canada left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1413 holding.
  • TD Waterhouse Canada first reported a position in Revolution Medicines in Q4 2023 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.